tRNA modification and cancer: potential for therapeutic prevention and intervention

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Chan PP, Lowe TM. GtRNAdb 2.0: an expanded database of transfer RNA genes identified in complete and draft genomes. Nucleic Acids Res. 44(D1), D184–D189 (2016).
  Medline CASGoogle Scholar
• 2 Marck C, Grosjean H. tRNomics: analysis of tRNA genes from 50 genomes of Eukarya, Archaea, and Bacteria reveals anticodon-sparing strategies and domain-specific features. RNA 8(10), 1189–1232 (2002).
  Medline CASGoogle Scholar
• 3 Dever TE, Green R. The elongation, termination, and recycling phases of translation in eukaryotes. Cold Spring Harb. Perspect. Biol. 4(7), a013706; 1–16 (2012).
  MedlineGoogle Scholar
• 4 Crick FH. Codon--anticodon pairing: the wobble hypothesis. J. Mol. Biol. 19(2), 548–555 (1966).
  Medline CASGoogle Scholar
• 5 Agris PF, Narendran A, Sarachan K, Vare VYP, Eruysal E. The importance of being modified: the role of RNA modifications in translational fidelity. Enzymes 41, 1–50 (2017).
  Medline CASGoogle Scholar
• 6 Agris PF, Vendeix FA, Graham WD. tRNA's wobble decoding of the genome: 40 years of modification. J. Mol. Biol. 366(1), 1–13 (2007).
  Medline CASGoogle Scholar
• 7 Svensson I, Bjork G, Bjork W, Johansson KE, Johansson A. Evidence for enzymatic methylation in vitro of the ribose moiety of RNA. Biochem. Biophys. Res. Commun. 31(2), 216–221 (1968).
  Medline CASGoogle Scholar
• 8 Towns WL, Begley TJ. Transfer RNA methytransferases and their corresponding modifications in budding yeast and humans: activities, predications, and potential roles in human health. DNA Cell Biol. 31(4), 434–454 (2012).
  Medline CASGoogle Scholar
• 9 Agris PF. Bringing order to translation: the contributions of transfer RNA anticodon-domain modifications. EMBO Rep. 9(7), 629–635 (2008).
  Medline CASGoogle Scholar
• 10 Capra JD, Peterkofsky A. Effect on in vitro methylation on the chromatographic and coding properties of methyl-deficient leucine transfer RNA. J. Mol. Biol. 33(3), 591–607 (1968).
  Medline CASGoogle Scholar
• 11 Karlsborn T, Tukenmez H, Mahmud AK, Xu F, Xu H, Bystrom AS. Elongator, a conserved complex required for wobble uridine modifications in eukaryotes. RNA Biol. 11(12), 1519–1528 (2015).
  Google Scholar
• 12 Shugart L, Chastain BH, Novelli GD, Stulberg MP. Restoration of aminoacylation activity of undermethylated transfer RNA by in vitro methylation. Biochem. Biophys. Res. Commun. 31(3), 404–409 (1968).
  Medline CASGoogle Scholar
• 13 Gefter ML, Russell RL. Role modifications in tyrosine transfer RNA: a modified base affecting ribosome binding. J. Mol. Biol. 39(1), 145–157 (1969).
  Medline CASGoogle Scholar
• 14 Phizicky EM, Hopper AK. tRNA biology charges to the front. Genes Dev. 24(17), 1832–1860 (2010).
  MedlineGoogle Scholar
• 15 Motorin Y, Helm M. tRNA stabilization by modified nucleotides. Biochemistry 49(24), 4934–4944 (2010).
  Medline CASGoogle Scholar
• 16 Chernyakov I, Whipple JM, Kotelawala L, Grayhack EJ, Phizicky EM. Degradation of several hypomodified mature tRNA species in Saccharomyces cerevisiae is mediated by Met22 and the 5’-3’ exonucleases Rat1 and Xrn1. Genes Dev. 22(10), 1369–1380 (2008).
  Medline CASGoogle Scholar
• 17 Alexandrov A, Chernyakov I, Gu W et al. Rapid tRNA decay can result from lack of nonessential modifications. Mol. Cell 21(1), 87–96 (2006).
  Medline CASGoogle Scholar
• 18 Gomez-Roman N, Grandori C, Eisenman RN, White RJ. Direct activation of RNA polymerase III transcription by c-Myc. Nature 421(6920), 290–294 (2003).
  Medline CASGoogle Scholar
• 19 Farabaugh PJ. Programmed translational frameshifting. Microbiol. Rev. 60(1), 103–134 (1996).
  Medline CASGoogle Scholar
• 20 Bjork G, Rasmuson T. Links between tRNA modification and metabolism and modified nucleosides as tumor markers. In: Modification and Editing of RNA. Grosjean H, Benne R (Eds). American Society for Microbiology, Washington, DC, 471–491 (1998).
  Google Scholar
• 21 Endres L, Dedon PC, Begley TJ. Codon-biased translation can be regulated by wobble-base tRNA modification systems during cellular stress responses. RNA Biol. 12(6), 603–614 (2015).
  MedlineGoogle Scholar
• 22 Doyle F, Leonardi A, Endres L, Tenenbaum SA, Dedon PC, Begley TJ. Gene- and genome-based analysis of significant codon patterns in yeast, rat and mice genomes with the CUT Codon UTilization tool. Methods 107, 98–109 (2016).
  Medline CASGoogle Scholar
• 23 Cantara WA, Crain PF, Rozenski J et al. The RNA Modification Database, RNAMDB: 2011 update. Nucleic Acids Res. 39, D195–D201 (2011).
  Medline CASGoogle Scholar
• 24 Sprinzl M, Horn C, Brown M, Ioudovitch A, Steinberg S. Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res. 26(1), 148–153 (1998).
  Medline CASGoogle Scholar
• 25 Chan CT, Dyavaiah M, Demott MS, Taghizadeh K, Dedon PC, Begley TJ. A quantitative systems approach reveals dynamic control of tRNA modifications during cellular stress. PLoS Genet. 6(12), 1–9; e1001247 (2010). • Identifies distinct signatures of tRNA modification chemistries for oxidative stress-inducing toxicants.
  CASGoogle Scholar
• 26 Chan CT, Pang YL, Deng W et al. Reprogramming of tRNA modifications controls the oxidative stress response by codon-biased translation of proteins. Nat. Commun. 3, 937 (2013). •• Describes an oxidative stress-induced tRNA modification system mediated by yeast Trm4 that enhances the translation of a stress-associated ribosomal protein.
  Google Scholar
• 27 Begley U, Dyavaiah M, Patil A et al. Trm9-catalyzed tRNA modifications link translation to the DNA damage response. Mol. Cell 28(5), 860–870 (2007). • Describes a tRNA modification system mediated by yeast Trm9 that responds to DNA damage and enhances the translation of proteins involved in DNA repair.
  Medline CASGoogle Scholar
• 28 Kalhor HR, Clarke S. Novel methyltransferase for modified uridine residues at the wobble position of tRNA. Mol. Cell. Biol. 23(24), 9283–9292 (2003).
  Medline CASGoogle Scholar
• 29 Deng W, Babu IR, Su D, Yin S, Begley TJ, Dedon PC. Trm9-catalyzed tRNA Modifications regulate global protein expression by codon-biased translation. PLoS Genet. 11(12), 1–23; e1005706 (2015).
  CASGoogle Scholar
• 30 Kew MC. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int. 23(6), 405–409 (2003).
  Medline CASGoogle Scholar
• 31 Baertschi SW, Raney KD, Shimada T, Harris TM, Guengerich FP. Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses. Chem. Res. Toxicol. 2(2), 114–112 (1989).
  Medline CASGoogle Scholar
• 32 Eaton DL, Gallagher EP. Mechanisms of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 34, 135–172 (1994).
  Medline CASGoogle Scholar
• 33 Guindon-Kezis KA, Mulder JE, Massey TE. In vivo treatment with aflatoxin B1 increases DNA oxidation, base excision repair activity and 8-oxoguanine DNA glycosylase 1 levels in mouse lung. Toxicology 321, 21–26 (2014).
  Medline CASGoogle Scholar
• 34 Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350(6317), 429–431 (1991).
  Medline CASGoogle Scholar
• 35 Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350(6317), 427–428 (1991).
  Medline CASGoogle Scholar
• 36 Keller-Seitz MU, Certa U, Sengstag C, Wurgler FE, Sun M, Fasullo M. Transcriptional response of yeast to aflatoxin B1: recombinational repair involving RAD51 and RAD1. Mol. Biol. Cell 15(9), 4321–4336 (2004).
  Medline CASGoogle Scholar
• 37 Fasullo M, Chen Y, Bortcosh W, Sun M, Egner PA. Aflatoxin B(1)-associated DNA adducts stall S phase and stimulate Rad51 foci in Saccharomyces cerevisiae. J. Nucleic Acids 2010, 1–9; 456487 (2010).
  Google Scholar
• 38 Fasullo M, Sun M, Egner P. Stimulation of sister chromatid exchanges and mutation by aflatoxin B1–DNA adducts in Saccharomyces cerevisiae requires MEC1 (ATR), RAD53, and DUN1. Mol. Carcinog. 47(8), 608–615 (2008).
  Medline CASGoogle Scholar
• 39 Songe-Moller L, Van Den Born E, Leihne V et al. Mammalian ALKBH8 possesses tRNA methyltransferase activity required for the biogenesis of multiple wobble uridine modifications implicated in translational decoding. Mol. Cell. Biol. 30(7), 1814–1827 (2010).
  MedlineGoogle Scholar
• 40 Fu D, Brophy JA, Chan CT et al. Human AlkB homolog ABH8 Is a tRNA methyltransferase required for wobble uridine modification and DNA damage survival. Mol. Cell. Biol. 30(10), 2449–2459 (2010). • Demonstrates a role for human ALKBH8 (yeast Trm9 homolog) and its associated mcm5U wobble base modification in the DNA damage response.
  Medline CASGoogle Scholar
• 41 Driscoll DM, Copeland PR. Mechanism and regulation of selenoprotein synthesis. Annu. Rev. Nutr. 23, 17–40 (2003).
  Medline CASGoogle Scholar
• 42 Carlson BA, Xu XM, Gladyshev VN, Hatfield DL. Selective rescue of selenoprotein expression in mice lacking a highly specialized methyl group in selenocysteine tRNA. J. Biol. Chem. 280(7), 5542–5548 (2005).
  Medline CASGoogle Scholar
• 43 Veal EA, Day AM, Morgan BA. Hydrogen peroxide sensing and signaling. Mol. Cell 26(1), 1–14 (2007).
  Medline CASGoogle Scholar
• 44 Endres L, Begley U, Clark R et al. Alkbh8 regulates selenocysteine-protein expression to protect against reactive oxygen species damage. PLoS ONE 10(7), 1–23; e0131335 (2015). • Connects ALKBH8 to the oxidative stress response via ALKBH8-dependent tRNASec(UCA) modifications that enhance the translation of selenocysteine-containing proteins.
  Google Scholar
• 45 Dedon PC, Begley TJ. A system of RNA modifications and biased codon use controls cellular stress response at the level of translation. Chem. Res. Toxicol. 27(3), 330–337 (2014).
  Medline CASGoogle Scholar
• 46 Gu C, Ramos J, Begley U, Dedon PC, Fu D, Begley TJ. Phosphorylation of human TRM9L integrates multiple stress-signaling pathways for tumor growth suppression. Sci. Adv. 4(7), 1–12; eaas9184 (2018).
  Google Scholar
• 47 Diehn M, Cho RW, Lobo NA et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239), 780–783 (2009).
  Medline CASGoogle Scholar
• 48 Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 24(5), 981–990 (2012).
  Medline CASGoogle Scholar
• 49 Sies H. Role of metabolic H2O2 generation: redox signaling and oxidative stress. J. Biol. Chem. 289(13), 8735–8741 (2014).
  Medline CASGoogle Scholar
• 50 Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 279(6), L1005–1028 (2000).
  Medline CASGoogle Scholar
• 51 Silvera D, Formenti SC, Schneider RJ. Translational control in cancer. Nat. Rev. Cancer 10(4), 254–266 (2010).
  Medline CASGoogle Scholar
• 52 Ruggero D. Translational control in cancer etiology. Cold Spring Harb. Perspect. Biol. 5(2), 1–27 (2013).
  Google Scholar
• 53 Truitt Ml, Ruggero D. New frontiers in translational control of the cancer genome. Nat. Rev. Cancer 16(5), 288–304 (2016).
  Medline CASGoogle Scholar
• 54 Charette M, Gray MW. Pseudouridine in RNA: what, where, how, and why. IUBMB Life 49(5), 341–351 (2000).
  Medline CASGoogle Scholar
• 55 Hamma T, Ferre-D'amare AR. Pseudouridine synthases. Chem. Biol. 13(11), 1125–1135 (2006).
  Medline CASGoogle Scholar
• 56 Borek E, Baliga BS, Gehrke CW et al. High turnover rate of transfer RNA in tumor tissue. Cancer Res. 37(9), 3362–3366 (1977).
  Medline CASGoogle Scholar
• 57 Craddock VM. Transfer RNA methylases and cancer. Nature 228(5278), 1264–1268 (1970).
  Medline CASGoogle Scholar
• 58 Borek E. Transfer RNA and transfer RNA modification in differentiation and neoplasia. Introduction. Cancer Res. 31(5), 596–597 (1971).
  Medline CASGoogle Scholar
• 59 Viale GL. Transfer RNA and transfer RNA methylase in human brain tumors. Cancer Res. 31(5), 605–608 (1971).
  Medline CASGoogle Scholar
• 60 Murphy TL, Cooper IA, Wray GW, Ironside PN, Matthews J. Transfer RNA and transfer RNA methylase activity in spleens of patients with Hodgkin's disease and histiocytic lymphoma. J. Natl Cancer Inst. 56(2), 215–219 (1976).
  Medline CASGoogle Scholar
• 61 Bullinger D, Neubauer H, Fehm T, Laufer S, Gleiter CH, Kammerer B. Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling. BMC Biochem. 8, 25 (2007).
  MedlineGoogle Scholar
• 62 Frickenschmidt A, Frohlich H, Bullinger D et al. Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients. Biomarkers 13(4), 435–449 (2008).
  Medline CASGoogle Scholar
• 63 Willmann L, Schlimpert M, Halbach S, Erbes T, Stickeler E, Kammerer B. Metabolic profiling of breast cancer: differences in central metabolism between subtypes of breast cancer cell lines. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1000, 95–104 (2015).
  Medline CASGoogle Scholar
• 64 Willmann L, Erbes T, Krieger S, Trafkowski J, Rodamer M, Kammerer B. Metabolome analysis via comprehensive two-dimensional liquid chromatography: identification of modified nucleosides from RNA metabolism. Anal. Bioanal. Chem. 407(13), 3555–3566 (2015).
  Medline CASGoogle Scholar
• 65 Dong C, Niu L, Song W et al. tRNA modification profiles of the fast-proliferating cancer cells. Biochem. Biophys. Res. Commun. 476(4), 340–345 (2016).
  Medline CASGoogle Scholar
• 66 Guzzi N, Ciesla M, Ngoc PCT et al. Pseudouridylation of tRNA-derived fragments steers translational control in stem cells. Cell 173(5), 1204–1216; e1226 (2018).
  Medline CASGoogle Scholar
• 67 Zhang Y, Shi J, Chen Q. tsRNAs: new players in mammalian retrotransposon control. Cell Res. 27(11), 1307–1308 (2017).
  Medline CASGoogle Scholar
• 68 Lee YS, Shibata Y, Malhotra A, Dutta A. A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev. 23(22), 2639–2649 (2009).
  Medline CASGoogle Scholar
• 69 Balatti V, Nigita G, Veneziano D et al. tsRNA signatures in cancer. Proc. Natl Acad. Sci. USA 114(30), 8071–8076 (2017).
  Medline CASGoogle Scholar
• 70 Srinivasan PR, Borek E. Enzymatic alteration of nucleic acid structure. Science 145(3632), 548–553 (1964).
  Medline CASGoogle Scholar
• 71 Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 100(1), 57–70 (2000).
  Medline CASGoogle Scholar
• 72 Begley U, Sosa MS, Avivar-Valderas A et al. A human tRNA methyltransferase 9-like protein prevents tumour growth by regulating LIN9 and HIF1-alpha. EMBO Mol. Med. 5(3), 366–383 (2013).
  Medline CASGoogle Scholar
• 73 Kerangueven F, Essioux L, Dib A et al. Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene 10(5), 1023–1026 (1995).
  Medline CASGoogle Scholar
• 74 Knowles MA, Shaw ME, Proctor AJ. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene 8(5), 1357–1364 (1993).
  Medline CASGoogle Scholar
• 75 Prasad MA, Trybus TM, Wojno KJ, Macoska JA. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site. Genes Chromosomes Cancer 23(3), 255–262 (1998).
  MedlineGoogle Scholar
• 76 Bardi G, Johansson B, Pandis N et al. Cytogenetic analysis of 52 colorectal carcinomas – non-random aberration pattern and correlation with pathologic parameters. Int. J. Cancer 55(3), 422–428 (1993).
  Medline CASGoogle Scholar
• 77 Rapino F, Delaunay S, Rambow F et al. Codon-specific translation reprogramming promotes resistance to targeted therapy. Nature 558(7711), 605–609 (2018). •• Connects the ELP3-initiated U34 tRNA modification system to oncogenic BRAF(V600E) in melanoma with implications for targeting drug-resistant cancers.
  Medline CASGoogle Scholar
• 78 Wang S, Liu X, Huang J et al. Expression of KIAA1456 in lung cancer tissue and its effects on proliferation, migration and invasion of lung cancer cells. Oncol. Lett. 16(3), 3791–3795 (2018).
  MedlineGoogle Scholar
• 79 Chen HM, Wang J, Zhang YF, Gao YH. Ovarian cancer proliferation and apoptosis are regulated by human transfer RNA methyltransferase 9-like via LIN9. Oncol. Lett. 14(4), 4461–4466 (2017).
  MedlineGoogle Scholar
• 80 Dimitriou M, Woll PS, Mortera-Blanco T et al. Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality. Oncotarget 7(45), 72685–72698 (2016).
  MedlineGoogle Scholar
• 81 Blanco S, Dietmann S, Flores JV et al. Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders. EMBO J. 33(18), 2020–2039 (2014).
  Medline CASGoogle Scholar
• 82 Blanco S, Bandiera R, Popis M et al. Stem cell function and stress response are controlled by protein synthesis. Nature 534(7607), 335–340 (2016). • Provides details about how NSUN2 controls protein expression to regulate stem cell function and the role that the stress response plays in this process.
  Medline CASGoogle Scholar
• 83 Brzezicha B, Schmidt M, Makalowska I, Jarmolowski A, Pienkowska J, Szweykowska-Kulinska Z. Identification of human tRNA:m5C methyltransferase catalysing intron-dependent m5C formation in the first position of the anticodon of the pre-tRNA Leu (CAA). Nucleic Acids Res. 34(20), 6034–6043 (2006).
  Medline CASGoogle Scholar
• 84 Tuorto F, Liebers R, Musch T et al. RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis. Nat. Struct. Mol. Biol. 19(9), 900–905 (2012).
  Medline CASGoogle Scholar
• 85 Anderson P, Ivanov P. tRNA fragments in human health and disease. FEBS Lett. 588(23), 4297–4304 (2014).
  Medline CASGoogle Scholar
• 86 Sobala A, Hutvagner G. Small RNAs derived from the 5’ end of tRNA can inhibit protein translation in human cells. RNA Biol. 10(4), 553–563 (2013).
  Medline CASGoogle Scholar
• 87 Ivanov P, Emara MM, Villen J, Gygi SP, Anderson P. Angiogenin-induced tRNA fragments inhibit translation initiation. Mol. Cell 43(4), 613–623 (2011).
  Medline CASGoogle Scholar
• 88 Khan MA, Rafiq MA, Noor A et al. Mutation in NSUN2, which encodes an RNA methyltransferase, causes autosomal-recessive intellectual disability. Am. J. Hum. Genet. 90(5), 856–863 (2012).
  Medline CASGoogle Scholar
• 89 Martinez FJ, Lee JH, Lee JE et al. Whole exome sequencing identifies a splicing mutation in NSUN2 as a cause of a Dubowitz-like syndrome. J. Med. Genet. 49(6), 380–385 (2012).
  Medline CASGoogle Scholar
• 90 Abbasi-Moheb L, Mertel S, Gonsior M et al. Mutations in NSUN2 cause autosomal-recessive intellectual disability. Am. J. Hum. Genet. 90(5), 847–855 (2012).
  Medline CASGoogle Scholar
• 91 Lu L, Zhu G, Zeng H, Xu Q, Holzmann K. High tRNA transferase NSUN2 gene expression is associated with poor prognosis in head and neck squamous carcinoma. Cancer Invest. 36(4), 246–253 (2018).
  Medline CASGoogle Scholar
• 92 Frye M, Watt FM. The RNA methyltransferase Misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors. Curr. Biol. 16(10), 971–981 (2006).
  Medline CASGoogle Scholar
• 93 Frye M, Dragoni I, Chin SF et al. Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer. Cancer Lett. 289(1), 71–80 (2010).
  Medline CASGoogle Scholar
• 94 Yi J, Gao R, Chen Y et al. Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer. Oncotarget 8(13), 20751–20765 (2017).
  MedlineGoogle Scholar
• 95 Goll MG, Kirpekar F, Maggert KA et al. Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 311(5759), 395–398 (2006).
  Medline CASGoogle Scholar
• 96 Khoddami V, Cairns BR. Identification of direct targets and modified bases of RNA cytosine methyltransferases. Nat. Biotechnol. 31(5), 458–464 (2013).
  Medline CASGoogle Scholar
• 97 Schaefer M, Pollex T, Hanna K et al. RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage. Genes Dev. 24(15), 1590–1595 (2010).
  Medline CASGoogle Scholar
• 98 Jeltsch A, Ehrenhofer-Murray A, Jurkowski TP et al. Mechanism and biological role of Dnmt2 in nucleic acid methylation. RNA Biol. 14(9), 1108–1123 (2017).
  MedlineGoogle Scholar
• 99 Tuorto F, Herbst F, Alerasool N et al. The tRNA methyltransferase Dnmt2 is required for accurate polypeptide synthesis during haematopoiesis. EMBO J. 34(18), 2350–2362 (2015).
  Medline CASGoogle Scholar
• 100 Huang B, Johansson MJ, Bystrom AS. An early step in wobble uridine tRNA modification requires the Elongator complex. RNA 11(4), 424–436 (2005).
  Medline CASGoogle Scholar
• 101 Bauer F, Matsuyama A, Candiracci J et al. Translational control of cell division by Elongator. Cell Rep. 1(5), 424–433 (2012).
  Medline CASGoogle Scholar
• 102 Ladang A, Rapino F, Heukamp LC et al. Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine. J. Exp. Med. 212(12), 2057–2075 (2015).
  Medline CASGoogle Scholar
• 103 Delaunay S, Rapino F, Tharun L et al. Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer. J. Exp. Med. 213(11), 2503–2523 (2016).
  Medline CASGoogle Scholar
• 104 Nguyen A, Rosner A, Milovanovic T et al. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression. Int. J. Oncol. 27(4), 949–956 (2005).
  Medline CASGoogle Scholar
• 105 Karoulia Z, Gavathiotis E, Poulikakos PI. New perspectives for targeting RAF kinase in human cancer. Nat. Rev. Cancer 17(11), 676–691 (2017).
  Medline CASGoogle Scholar
• 106 Okamoto M, Hirata S, Sato S et al. Frequent increased gene copy number and high protein expression of tRNA (cytosine-5-)-methyltransferase (NSUN2) in human cancers. DNA Cell Biol. 31(5), 660–671 (2012).
  Medline CASGoogle Scholar
• 107 Schaefer M, Hagemann S, Hanna K, Lyko F. Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines. Cancer Res. 69(20), 8127–8132 (2009).
  Medline CASGoogle Scholar
• 108 Stresemann C, Lyko F. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int. J. Cancer 123(1), 8–13 (2008).
  Medline CASGoogle Scholar
• 109 Forbes SA, Beare D, Gunasekaran P et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 43, D805–D811 (2014).
  MedlineGoogle Scholar
• 110 Elhardt W, Shanmugam R, Jurkowski TP, Jeltsch A. Somatic cancer mutations in the DNMT2 tRNA methyltransferase alter its catalytic properties. Biochimie 112, 66–72 (2015).
  Medline CASGoogle Scholar
• 111 Rodriguez V, Chen Y, Elkahloun A, Dutra A, Pak E, Chandrasekharappa S. Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer. Genes Chromosomes Cancer 46(7), 694–707 (2007).
  Medline CASGoogle Scholar
• 112 Shimada K, Nakamura M, Anai S et al. A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression. Cancer Res. 69(7), 3157–3164 (2009).
  Medline CASGoogle Scholar
• 113 Ohshio I, Kawakami R, Tsukada Y et al. ALKBH8 promotes bladder cancer growth and progression through regulating the expression of survivin. Biochem. Biophys. Res. Commun. 477(3), 413–418 (2016).
  Medline CASGoogle Scholar
• 114 Burger M, Catto JW, Dalbagni G et al. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 63(2), 234–241 (2013).
  MedlineGoogle Scholar
• 115 Hempel N, Ye H, Abessi B, Mian B, Melendez JA. Altered redox status accompanies progression to metastatic human bladder cancer. Free Radic. Biol. Med. 46(1), 42–50 (2009).
  Medline CASGoogle Scholar
• 116 Hempel N, Melendez JA. Intracellular redox status controls membrane localization of pro- and anti-migratory signaling molecules. Redox Biol. 2, 245–250 (2014).
  Medline CASGoogle Scholar
• 117 Hempel N, Carrico PM, Melendez JA. Manganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis. Anticancer Agents Med. Chem. 11(2), 191–201 (2011).
  Medline CASGoogle Scholar
• 118 Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist. Updat. 7(2), 97–110 (2004).
  Medline CASGoogle Scholar
• 119 Goodarzi H, Nguyen HCB, Zhang S, Dill BD, Molina H, Tavazoie SF. Modulated expression of specific tRNAs drives gene expression and cancer progression. Cell 165(6), 1416–1427 (2016). •• Demonstrates that the upregulation of tRNAArg(CCG) and tRNAGlu(UUC) can promote the metastatic behavior of breast cancer cells through enhanced codon-biased translation.
  Medline CASGoogle Scholar
• 120 Novoa EM, Ribas DE, Pouplana L. Speeding with control: codon usage, tRNAs, and ribosomes. Trends Genet. 28(11), 574–581 (2012).
  Medline CASGoogle Scholar
• 121 Dittmar KA, Goodenbour JM, Pan T. Tissue-specific differences in human transfer RNA expression. PLoS Genet. 2(12), e221 (2006).
  MedlineGoogle Scholar
• 122 Tuller T, Carmi A, Vestsigian K et al. An evolutionarily conserved mechanism for controlling the efficiency of protein translation. Cell 141(2), 344–354 (2012a).
  Google Scholar
• 123 Gingold H, Tehler D, Christoffersen NR et al. A dual program for translation regulation in cellular proliferation and differentiation. Cell 158(6), 1281–1292 (2014).
  Medline CASGoogle Scholar
• 124 Pavon-Eternod M, Gomes S, Geslain R, Dai Q, Rosner MR, Pan T. tRNA over-expression in breast cancer and functional consequences. Nucleic Acids Res. 37(21), 7268–7280 (2009).
  Medline CASGoogle Scholar
• 125 Olvedy M, Scaravilli M, Hoogstrate Y, Visakorpi T, Jenster G, Martens-Uzunova ES. A comprehensive repertoire of tRNA-derived fragments in prostate cancer. Oncotarget 7(17), 24766–24777 (2016).
  MedlineGoogle Scholar
• 126 Goodarzi H, Liu X, Nguyen HC, Zhang S, Fish L, Tavazoie SF. Endogenous tRNA-derived fragments suppress breast cancer progression via YBX1 displacement. Cell 161(4), 790–802 (2015).
  Medline CASGoogle Scholar
• 127 Fasullo M, Freedland J, St John N et al. An in vitro system for measuring genotoxicity mediated by human CYP3A4 in Saccharomyces cerevisiae. Environ. Mol. Mutagen. 58(4), 217–227 (2017).
  Medline CASGoogle Scholar
• 128 Lampson BL, Pershing NL, Prinz JA et al. Rare codons regulate KRas oncogenesis. Curr. Biol. 23(1), 70–75 (2013).
  Medline CASGoogle Scholar